Dr Yassir Javaid presents a series of ‘reverse case-study’ presentations and discussions with fellow experts, looking at how cardiovascular outcomes can be improved.
3 CPD modules providing concise evidence-based guidance to contemporary medications and their application in daily care with the aim of assessing the clinical evidence and opportunities offered by sodium-glucose co-transporter-2 (SGLT2) inhibitors in the management of type 2 diabetes and its cardio-renal complications.
An expert-led programme telling you everything you need to know about important new evidence on the clinical value of SGLT2 inhibitors which significantly affects best practice in primary care.